EP1799335A2 - Compositions et procedes permettant de retirer des metaux lourds d'echantillons contamines au moyen de membranes comportant des proteines metallothioneines purifiees (mt) - Google Patents

Compositions et procedes permettant de retirer des metaux lourds d'echantillons contamines au moyen de membranes comportant des proteines metallothioneines purifiees (mt)

Info

Publication number
EP1799335A2
EP1799335A2 EP05812434A EP05812434A EP1799335A2 EP 1799335 A2 EP1799335 A2 EP 1799335A2 EP 05812434 A EP05812434 A EP 05812434A EP 05812434 A EP05812434 A EP 05812434A EP 1799335 A2 EP1799335 A2 EP 1799335A2
Authority
EP
European Patent Office
Prior art keywords
metal
metal binding
seq
membrane
binding proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05812434A
Other languages
German (de)
English (en)
Inventor
Roger A. Acey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MGP Biotechnologies LLC
Original Assignee
MGP Biotechnologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MGP Biotechnologies LLC filed Critical MGP Biotechnologies LLC
Publication of EP1799335A2 publication Critical patent/EP1799335A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/825—Metallothioneins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/14—Dynamic membranes
    • B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
    • B01D69/1411—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes containing dispersed material in a continuous matrix
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26—Synthetic macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26—Synthetic macromolecular compounds
    • B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/28033—Membrane, sheet, cloth, pad, lamellar or mat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8259—Phytoremediation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
    • B01J2220/48—Sorbents characterised by the starting material used for their preparation
    • B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
    • B01J2220/4856—Proteins, DNA
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/28—Treatment of water, waste water, or sewage by sorption
    • C02F1/286—Treatment of water, waste water, or sewage by sorption using natural organic sorbents or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/20—Heavy metals or heavy metal compounds

Definitions

  • the present invention relates to compositions and methods for removing heavy metals from contaminated samples. More specifically the present invention relates to removing heavy metals from contaminated samples using solid supports having metallothionein proteins bound thereto.
  • Metal recovery can be from innumerable and varied sources such as from waste electronic devices (transistors, chips, transformers, bus bars, cathodes, and microprocessors, populated computer circuit boards PCBs, motherboards). Costs associated with hazardous disposal of industrial waste in the absence of metal reclamation are enormous. Therefore, metal recycling or reuse of metal extracted from scrap or discarded metal-containing items not only reduces the volume and cost of metal waste requiring specialized disposal and handling efforts, but the reclaimed metal can also be resold or reused to provide additional economic value.
  • Prior art attempts at treating metal contamination have traditionally employed cleanup technologies which consist primarily of physically removing and then disposing of contaminated matter. These methodologies are not only labor intensive and less efficient, but also carry a high expense associated with removal and disposal of large or bulk quantities of contaminated waste. Metal contamination is especially difficult to remediate because unlike other types of waste such as chemical or organic matter, metals cannot be directly destroyed or converted.
  • current technologies for remediating metal contaminated soils consist primarily of landfilling or soil excavation with physical or chemical separation of the metal contaminants.
  • Treatment of contaminated ground water usually involves flushing, filtration or chemical extraction to remove the contaminating metals. As a result, the cost of soil or ground water remediation is high, ranging in the hundreds to thousands of millions of dollars in projected five-year costs per site (U.S. EPA, 1993).
  • the risk to humans and the environment from heavy metal contamination is not limited to soil or ground water, but also includes other sources such as industrial waste, sludge waste, wastewater, radioactive waste (such as radionuclides from research and medical waste) and mining waste.
  • other sources such as industrial waste, sludge waste, wastewater, radioactive waste (such as radionuclides from research and medical waste) and mining waste.
  • radioactive waste such as radionuclides from research and medical waste
  • mining waste Depending on the physical and chemical form of the metal contaminant to be removed, as well as the cost-benefit analysis for a particular remediation approach, which of the existing technologies is better suited for a particular site will vary.
  • due to the high cost of traditional cleanup technologies there still remains a great need for a less-expensive, safe and effective heavy metal recovery and cleanup technology.
  • Isolation technologies utilize a containment strategy in an attempt to confine a contaminated site or area so as to prevent further spread of the toxic metal waste.
  • Immobilization technologies reduce the mobility of metal contaminants and include systems which provide an impermeable barrier to separate underlying layers of soil (containing the metal contaminants) from the topsoil layer. Also used are physical barriers which restrict the flow of uncontaminated groundwater through a contaminated site.
  • toxicity reduction processes which generally use chemical or biological techniques to decrease the toxicity or mobility of metal contaminants. Included in toxicity reduction processes are biological treatment technologies, which apply newer biotechnical approaches.
  • Metal remediation is a relatively new application of biological treatment technologies and includes processes such as bioaccumulation, phytoremediation, phyotextraction, and rhizofiltration. All of these biological treatments use certain plants and microorganisms to remediate metals through either adsorption, absorption, or concentration of contaminating metal ions. For example, in bioaccumulation, plants or microorganisms actively take up and accumulate metals from contaminated surroundings.
  • Metallothioneins are small metal binding proteins ubiquitously distributed throughout the animal kingdom. They have high metal binding affinities and are believed to be important in controlling the intracellular levels of free metal ions. However, little else is known about their function or biological purpose. Metallothioneins were first discovered in 1957 in horse tissue. Since then, they have been identified in species ranging from fungi and shellfish to mice and humans.
  • MTs The structural features of MTs include a high cysteine composition and lack of aromatic amino acids.
  • the cysteine residues are responsible for the protein's high affinity metal ion binding capabilities.
  • MTs have a high degree of amino acid sequence similarity.
  • the proteins or known gene sequences encoding the proteins have been used primarily in either the research setting or in disease treatment methodologies.
  • one of the objects of the present invention is to provide novel metal binding proteins for the removal of metals from a variety of substrates. This technology would allow for the efficient, cost effective, safe and simple removal of heavy metals from environmental waste or other materials contaminated with heavy metal.
  • Metallothionein (MT) proteins are generally about 60-68 amino acid residues in size and have a high degree of sequence conservation among the different species. In contrast, MTs from brine shrimp ⁇ Artemia) are much smaller in size (about 48 amino acid residues) and have distinctly unique amino acid and DNA sequences.
  • the metal binding proteins of the present invention are capable of high capacity and high affinity metal binding. This makes them particularly suitable for use in pollution control, metal recycling, metal mining and other metal recovery and metal remediation technologies.
  • compositions and methods of the present invention which provide for the efficient and reliable sequestration of heavy metals from a variety of sources using a regenerative metal binding support comprised of at least one metal binding protein immobilized on a solid support.
  • the metal binding proteins can be expressed and produced easily for purposes such as metal remediation, metal recycling, metal mining or other types of processes where binding of one or more heavy metals is desired.
  • the metal binding protein is from the brine shrimp (Artemia) and has the amino acid sequence of SEQ ID NO. 2 or SEQ ID NO. 4.
  • the metal binding protein sequences incorporate one or more conservative amino acid substitutions of SEQ ID NO. 2 or SEQ ID NO. 4. It should be noted that while the metal binding proteins will be discussed in the context of metal recovery and metal remediation, the proteins are readily applicable to many other uses where removal, recovery or simply binding of heavy metals or heavy metal complexes is desired.
  • the novel metal binding proteins can be utilized as a naked composition or can be provided in association with a support, or other delivery system to aid in either the dispersal, handling, packaging or function of the metal binding proteins in metal recovery, metal remediation or metal binding processes as disclosed herein. Therefore, any of the metal binding proteins of the present invention can be coupled to a support such as a membrane filter, to form a regenerative metal binding support, through which metal containing fluids are brought into contact.
  • the present invention is particularly well suited for use in metal recovery, metal remediation or metal recycling processes and methods. These methods include contacting a metal binding protein of the present invention having an amino acid sequence analogous to at least one metal binding protein sequence from brine shrimp (Artemia) with a substrate or material having a concentration of at least one heavy metal in order to bind the metal to the metal binding protein; and then separating the bound metal from the substrate or material.
  • a metal binding protein of the present invention having an amino acid sequence analogous to at least one metal binding protein sequence from brine shrimp (Artemia) with a substrate or material having a concentration of at least one heavy metal in order to bind the metal to the metal binding protein; and then separating the bound metal from the substrate or material.
  • the metal binding proteins, and devices comprising them, disclosed herein are useful in connection with the treatment of any substrate having a concentration of at least one metal, such as a heavy metal.
  • a heavy metal such as a heavy metal
  • such heavy metal containing substrates can be any environmental or industrial material such as ground water, drinking water, contaminated soil, waste, or the like, containing a concentration of metal.
  • the methods of the present invention are equally useful in treating industrial or municipal wastes containing metals that are desirable to remove. This broad utility makes the compositions and associated methods of the present invention particularly useful in a wide variety of circumstances.
  • the metal binding proteins of the present invention retain high binding affinity for heavy metals in a variety of conditions, making them particularly useful in situations where removal or recovery of heavy metals from a substrate or any metal containing or metal contaminated source is desired.
  • the metal binding proteins and the associated methods of the present invention provide for the efficient, cost effective, and safe removal and recovery of heavy metals from a wide variety of substrates.
  • a device for removing heavy metals from a substrate comprising: a regenerative metal binding support comprising a polymer membrane having associated therewith and at least one substantially purified metallothionein (MT) protein, or a portion thereof, from an organism selected from the group consisting of mammals, fish, mollusks, echinoderms, crustaceans, reptiles, nematodes, grains and yeast; wherein the regenerative metal binding support binds heavy metals thereby removing the heavy metals from the substrate; and the binding of heavy metal to the regenerative metal binding support is reversible and wherein the regenerative metal binding support is reusable.
  • MT metallothionein
  • the mammal is a human, a monkey or a rabbit; the fish is a catfish; the mollusk is mussel; the echinoderm is a sea urchin; the reptile is a frog, the grain is rice or wheat and the crustacean is a brine shrimp (Artemia).
  • the MT protein has an amino acid sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO. 4, SEQ ID NO. 11 , SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21 , SEQ ID NO. 21 and SEQ ID NO. 23.
  • the polymer membrane is nylon.
  • the substrate is a liquid.
  • the heavy metal is a heavy metal complex.
  • a method for removing metals from a substrate comprising contacting a substrate having heavy metals therein with a regenerative metal binding support comprising a polymer membrane having associated therewith at least one substantially purified metallothionein (MT) protein, or a portion thereof, from an organism selected from the group consisting of mammals, fish, mollusks, echinoderms, crustaceans, reptiles, nematodes, grains and yeast; binding the heavy metal to the regenerative metal binding support thereby producing a substrate having less heavy metal contained therein.
  • MT metallothionein
  • the polymer membrane is nylon.
  • the heavy metal is a heavy metal complex.
  • the substrate is a liquid.
  • the method further comprises releasing the bound heavy metal from the regenerative metal binding support; and regenerating the metal-binding capacity of the regenerative metal binding support.
  • FIG. 1 is an elution profile of exemplary metal binding proteins of the present invention illustrating co-elution of metal binding proteins with the heavy metal zinc.
  • FIG. 2 is a map of an exemplary cloning cassette containing the gene sequence of the metal binding protein gene, in accordance with the teachings of the present invention.
  • FIG. 3 illustrates metallothionein (MT) protein selectively binding heavy metals in solution in accordance with the teachings of the present invention.
  • FIG. 4 illustrates MT proteins coupled to a solid support in accordance with the teachings of the present invention.
  • FIG. 5 illustrates the removal of heavy metals from water in accordance with the teachings of the present invention.
  • FIG. 6 illustrates the recovery of removed metals from a membrane coated with MT proteins in accordance with the teachings of the present invention.
  • FIG. 7 illustrates the selectivity and affinity of the present invention for binding heavy metals.
  • FIG. 8 depicts the sequence homology in the cysteine metal binding motifs between metallothionein proteins isolated from divergent species.
  • Metal binding proteins such as metallothioneins (MTs) that have been isolated from various species such as humans, mice, bacteria species, crabs, fish, yeast and chickens, are known to have very similar structural characteristics such as similar size (about 6.0-6.8 kDa), high amino acid sequence conservation, and a high percentage of cysteine residues in the proteins' total amino acid compositions. It is the cysteine composition of these MTs that accounts for the protein's binding affinity for heavy metals including, but not limited to, arsenic, zinc, copper, cadmium, mercury, cobalt, lead, nickel, chromium, uranium, platinum, silver and gold. Unless otherwise stated, the term protein refers to proteins, polypeptides and peptides.
  • the metal binding proteins of the present invention also bind heavy metals complexes in which the heavy metals are associated with a protein or other molecule.
  • the metal binding proteins, and devices comprising them, called regenerative metal binding supports, disclosed herein are useful in connection with the treatment of any substrate having a concentration of at least one metal, such as a heavy metal.
  • a heavy metal such as a heavy metal.
  • such heavy metal containing substrates can be any environmental or industrial material such as ground water, drinking water, contaminated soil, waste, or the like, containing a concentration of metal.
  • the methods of the present invention are equally useful in treating industrial or municipal wastes containing metals that are desirable to remove. This broad utility makes the compositions and associated methods of the present invention particularly useful in a wide variety of circumstances.
  • the metal binding proteins and regenerative metal binding supports of the present invention are useful in the recovery of metals, particularly precious metals from metal-containing substrates.
  • the metal binding proteins of the present invention can be used in metal mining processes for the isolation and removal of precious metals such as gold, platinum and silver. Doing so eliminates the need to use other toxic materials such as cyanide in the final stages of metal purification from ore.
  • These same novel techniques can be utilized to recover such metals from industrial or municipal waste. With the ever- increasing use of disposable and other electronic devices, such waste sources are increasingly full of such metals, making recovery a worthwhile endeavor.
  • the metal binding proteins of the present invention can be isolated easily and efficiently from natural sources or synthetically produced as disclosed herein for use in metal recovery, metal mining, metal recycling, metal remediation, pollution control or any process including metal sequestering. Therefore, the metal binding proteins and associated methods of the present invention provide a versatile, easily produced, efficient and reliable resource for use in any process having a metal binding aspect.
  • metal binding proteins were isolated from brine shrimp (Artemia).
  • Artemia MT are a family of metal binding proteins that are referred to as "isomers”. Analysis of these proteins' unique amino acid compositions showed each isoform to be essentially equivalent. At least five individual Artemia MT isoforms have been identified in accordance with the teachings of the present invention. Unlike MTs from other organisms which share a high degree of sequence homology or similarity, the Artemia metal binding proteins have unexpectedly different structural characteristics but possess a high degree of sequence homology to one another.
  • oligonucleotide primers corresponding to the N-terminal amino acid sequence were constructed as known in the art. These oligonucleotide primers were used to amplify, by polymerase chain reaction (PCR) potential candidates for a MT gene sequence encoding at least one of the target metal binding proteins from brine shrimp ⁇ Artemia).
  • PCR polymerase chain reaction
  • the PCR product was purified using QiaPrep spin columns (Qiagen, Inc.) and cloned into the TA cloning vector CR2.1 (Invitrogen) using the manufacturer's protocol.
  • Electrocompetent Escherichia coli (Sure Shot cells from Invitrogen) were transformed with the recombinant vector and plated onto LB agar plates containing ampicillin (100 /vg/ml) and 1% glucose. The plates were placed at 37°C overnight. Individual colonies were picked and used to inoculate 5 mL of LB broth supplemented with ampicillin and 1% glucose. The cultures were incubated overnight in a rotary incubator at 37°C. Plasmid was isolate from 2 mL of the cell suspension using QiaPrep spin columns as per the manufacturer's protocol (Qiagen). The plasmid was then sequenced on a Li Cor 4200L using the M13 universal forward and reverse primers.
  • the brine shrimp MT gene was subcloned into the bacterial expression vector pTMZ. Based upon the identified MT encoding sequence, the amino acid sequence of the first novel metal binding proteins of the present invention was determined.
  • FIG. 1 details an exemplary elution profile utilizing an exemplary metal binding protein of the present invention.
  • This profile was obtained utilizing the following exemplary protocol.
  • E. coli strain ER 2566
  • Bacteria were grown in LB broth containing 1% glucose at 37°C to an A 6 Oo of 0.60.
  • the bacterial cells were collected and resuspended in LB broth containing 0.1% glucose and incubated for 45 minutes at the same temperature, lsopropyl b-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM.
  • IPTG lsopropyl b-D-thiogalactopyranoside
  • the bacterial cells were incubated for about 16 hours. Non- transformed bacteria were used as controls.
  • the cells were collected by centrifugation and sonicated in 10 mM Tris, pH 8.0, 5 mM dithiothreitol (DTT) and 0.5 mM phenylmethylsulfonylfluoride (PMSF).
  • the homogenate was centrifuged at 150,000 x g for 1 hour at 4°C.
  • the supernatant was collected and incubated with 2 ⁇ Ci of 109 Cd at room temperature.
  • the radiolabeled supernatant was then applied to a G-50 molecular exclusion column and eluted with 50 r ⁇ M Tris, pH 8.0.
  • the present invention provides substantially purified metal binding proteins for use in removal of metals from metal-containing substrates by reversibly binding the metal to the metal binding proteins immobilized on a solid support.
  • substantially purified refers to nucleic acids, amino acids or proteins that have been removed from their natural environment, isolated or separated and are at least 60% free, preferably 75% free, to 90% or more free from other components with which they are naturally associated.
  • a substantially purified metal binding protein in accordance with the teachings of the present invention has an amino acid sequence analogous to:
  • substantially purified metal binding proteins that are variants of the sequence of the above SEQ ID NO. 2 that preserve the protein's metal binding affinity.
  • conservative amino acid substitutions within the scope of the present can include any of the following: (1 ) any substitution of isoleucine for leucine or valine, leucine for isoleucine, and valine for leucine or isoleucine; (2) any substitution of aspartic acid for glutamic acid and of glutamic acid for aspartic acid; (3) any substitution of glutamine for asparagine and of asparagine for glutamine; and (4) any substitution of serine for threonine and of threonine for serine.
  • a "conservative amino acid substitution” as used herein, refers to alteration of an amino acid sequence by substituting an amino acid having similar structural or chemical properties. Those skilled in the art can determine which amino acid residues may be substituted, inserted or altered without the metal binding properties of the proteins of the present invention. [0050] Other substitutions can also be considered conservative, depending upon the environment of the particular amino acid. For example, glycine and alanine can be interchangeable, as can be alanine and valine. Methionine, which is relatively hydrophobic, can be interchanged frequently with leucine and isoleucine, and sometimes with valine.
  • Lysine and arginine are interchangeable in locations in which the significant feature of the amino acid residue is its charge and the different pKs of these two amino acid residues and where their different sizes are not significant. Still other changes can be considered "conservative" in particular environments, as known in the art.
  • amino acids on the surface of a protein are not involved in a hydrogen bond or salt bridge interaction with another molecule, such as another protein subunit or a ligand bound by the protein
  • negatively charged amino acids such as glutamic acid and aspartic acid
  • positively charged amino acids such as lysine or arginine and vice versa.
  • Histidine which is more weakly basic than arginine or lysine, and is partially charged at neutral pH, can sometimes be substituted for these more basic amino acids as well.
  • the amides glutamine and asparagine can sometimes be substituted for their carboxylic acid homologues, glutamic acid and aspartic acid.
  • the Artemia metal binding proteins of the present invention are a family of metal binding proteins having multiple isomeric forms.
  • the present invention includes at least five isomeric forms of Artemia metal binding proteins suitable for use in removal or recovery of heavy metals.
  • An isomer is one of two or more compounds that have the same chemical composition but differ in structural form.
  • the "isomers" of the present invention have the requisite structural features that classify them as metal binding proteins. These features include their high cysteine content, which confers their metal binding capacity.
  • the isomers differ by two or more amino acid residues, resulting in different pi's for the individual isomer. This pi difference allows easy separation and characterization of the isoforms. Therefore, the metal binding proteins of the present invention can be expressed and produced efficiently and with ease.
  • these metal binding proteins In addition to their metal binding properties, these metal binding proteins also exhibit features which render them particularly useful in a wide variety of metal recovery and metal remediation settings. For example, these metal binding proteins are capable of heavy metal binding under a range of conditions such as under moderate to high temperature conditions. The metal binding proteins are capable of heavy metal binding at room temperature and therefore particularly ideal for many applications. The metal binding proteins are also capable of heavy metal binding within a wide temperature range such as, for example, a temperature range of about 4°C to about 100 0 C. Those skilled in the art will appreciate that depending on a particular application or operation in which the metal binding proteins are to be utilized, a particular temperature range may be preferred for practical or economic reasons.
  • a suitable range of temperatures for practicing the present invention includes a range of about 4°C to about 100 0 C. This range of temperature conditions makes the metal binding proteins of the present invention more versatile and useful.
  • the metal binding proteins can be utilized as a naked composition or in association with a support or dispersal means to aid in either the dispersal, handling, packaging or function of the metal binding protein in metal recovery, metal remediation or metal binding processes.
  • Such metal binding proteins are particularly useful in metal recovery, metal remediation and metal binding processes because they can be more easily and safely used as compared to other methodologies, such as chemical extraction, which exposes the user to toxic or other potentially dangerous types of chemicals.
  • a variety of solid supports to aid in the handling or dispersal of the novel metal binding proteins can be used and include a hydrophilic membrane, partially hydrophilic membrane, composite membrane, porous organic solid support, nonporous organic solid support, porous inorganic solid support, nonporous inorganic solid supports and combinations thereof. If the solid support is a membrane, membranes such as those described in U.S. Pat. Nos. 5,618,433 and 5,547,760, both of which are herein incorporated by reference in their entirety, are exemplary.
  • solid supports include sand, silicas, silicates, silica gel, glass, glass beads, glass fibers, alumina, zirconia, titania, nickel oxide polyacrylate, polystyrene, polyphenol and others as described in U.S. Pat. Nos. 4,943,375, 4,952,321 , 4,959,153, 4,960,882, 5,039,419, 5,071,819, 5,078,978, 5,084,430, 5,173,470, 5,179,213, 5,182,251 , 5,190,661 , 5,244,856, 5,273,660 and 5,393,892 which are herein incorporated by reference. Specific examples include flexible membranes, beads or particulates, filters, or any other solid supports known in the art that are useful for separations.
  • the solid support is in the form of a membrane.
  • the membrane is a polymer, and more preferably is a member selected from the group consisting of fluorinated polymers, polyolefins, polystyrene, substituted polystyrenes, polysulfones, polyesters, polyacrylates, polycarbonates; vinyl polymers, copolymers of butadiene and styrene, fluorinated ethylene-propylene copolymers, ethylenechlorotrifluoroethylene copolymers, nylon and mixtures thereof.
  • the metal binding proteins of the present invention are associated with a support, such as a polymer membrane, by covalent bonding of the metal binding protein to the polymer to by non-covalent binding such as, but not limited to, electrostatic attractions, dispersion forces and solvent-mediated forces.
  • At least one metal binding protein is associated with a solid support such that a regenerative metal binding support is provided, wherein the regenerative metal binding support can bind heavy metals from a substrate, the heavy metals can be released from the regenerative metal binding support and the regenerative metal binding support can be reused to bind heavy metalss.
  • a substrate from which one or more heavy metal species are to be removed is contacted with a metal binding protein bound to a solid support, where the metal binding protein has an affinity for the heavy metal.
  • the solid support forms a support for the metal binding protein and can be in the form of a membrane, beads or solid support particulates, or any other form commonly used in biochemical or chemical separations. If a membrane is used as the solid support, the metal binding protein- solid support composition can be incorporated into a contacting device comprising a housing, e.g., cartridge, containing the composition of matter of the invention by causing solution containing desired ions to flow through the cartridge and thus come in contact with the composition of the invention.
  • the membrane configuration is a pleated membrane, although other membrane configurations, such as flat sheet, stacked disk or hollow fibers may be used.
  • various contact apparatus may be used instead of a cartridge such as but not limited to a cassette, syringe, unit, canister, multi-well plate or filter holder. If a solid support is used, separation columns can be used as are known in the art.
  • an additional characteristic feature of the metal binding proteins are that they are also capable of reversible heavy metal binding.
  • bound metals can be eluted off or away from the metal binding proteins using acidic conditions or by instantaneous exchange reactions or inorganic chelators.
  • the 109 Cd metal exchanges for endogenous metal bound to the metal binding protein.
  • the metal is released from the protein.
  • Bringing the pH of the solution up to about pH 8.0 regenerates the metal binding activity of the protein. Therefore, due to the reversible binding characteristics of the novel metal binding proteins, the present invention also provides compositions, formulations, powders, liquids, devices or apparatuses comprising the substantially purified metal binding proteins which can be utilized more than once.
  • the isolation process comprises: (1) preparation of one or more sample(s) containing nucleic acids from brine shrimp (Artemia); (2) isolation of total RNA from Artemia; (3) preparation of cDNA from the total RNA; (4) amplification of metal binding protein gene sequences; and (5) cloning, sequencing and verification of an isolated nucleic acid sequence as a metal binding protein gene (MT) from brine shrimp (Artemia).
  • MT metal binding protein gene
  • MT proteins Species as divergent as humans and wheat express metallothionein proteins with similar binding affinities for heavy metals. These MT proteins contain from 12 to 22 cysteine residues, which are conserved across divergent species. These cysteine residues form metal binding motifs responsible for the metal binding function of the proteins (Hamer DH, Metallothionein. Ann. Rev. Biochem. 55:813-51 , 1986). Therefore, one embodiment of the present invention provides MT proteins immobilized on solid supports, such as membranes, wherein the MT are isolated from organisms including, but not limited to, mammals, fish, mollusks, echinoderms, crustaceans, reptiles, nematodes, grains and yeast.
  • Non-limiting examples of these organisms include, but are not limited to, brine shrimp (Artemia), rabbit (Oryctolagus cuniculus), green monkey (Cercopithecus aethiops), human (Homo sapiens), channel catfish (lctalurus punctatus), African clawed frog (Xenopus laevis), blue mussel (Mytilus edulis), painted sea urchin (Lytechinus pictus), fruit fly (Drosophila melanogaster), roundworm (Caenorhabditis elegans), rice (Oryza sativa), wheat (Thticum aestivum) and yeast (Candida glabrata).
  • One embodiment of the present invention provides one or more nucleic acid sequences encoding a substantially purified metal binding protein having amino acid sequence analogous to at least one metallothionein protein from an organism including, but not limited to, Artemia, mammals and marine species, or other species having a metallothionein protein with conserved amino acid sequence homology in the cysteine residues, e.g. the metal binding motifs, as compared to Artemia MT (FIG. 8).
  • Another embodiment of the present invention provides one or more amino acid sequences encoding a substantially purified metal binding protein analogous to at least one metallothionein protein from an organism including, but not limited to, Artemia, mammals and marine species, or other species having a metallothionein protein with conserved amino acid sequence homology in the cysteine residues, e.g. the metal binding motifs, as compared to Artemia MT (FIG. 8).
  • Exemplary amino acid sequences include the sequences of SEQ ID NO. 2 and SEQ ID NOs. 11-23 (FIG. 8).
  • an isolated nucleic acid can comprise the minimal DNA sequences sufficient to allow translation of a functional metal binding protein.
  • a functional metal binding protein need not be the entire native metal binding protein but can be just those portions or regions of SEQ ID NO. 1 that encodes a protein capable of binding to heavy metals. Therefore, the invention also includes isolated nucleic acids including DNA having at least 80% sequence identity to a DNA molecule having the sequence of nucleotide residues 1 to 66 of SEQ ID NO 1.
  • novel metal binding proteins of the present invention can have molecular weight of about 5,800 daltons and are able to bind with high affinity to heavy metal ions such as arsenic, zinc, copper, cadmium, mercury, cobalt, lead, nickel, platinum, silver and gold.
  • novel metal binding proteins include therein an amino acid sequence selected from the group consisting of: SEQ ID NO: 2 and sequences incorporating one or more conservative amino acid substitutions thereof wherein the conservative amino acid substitutions are any of the following: (1) any of isoleucine, leucine and valine for any other of these amino acids; (2) aspartic acid for glutamic acid and vice versa; (3) glutamine for asparagine and vice versa; and (4) serine for threonine and vice versa.
  • Alternative nucleic acid sequences can be determined using the standard genetic code; the alternative codons are readily determinable for each amino acid in this sequence.
  • nucleic acids provided herein can be used to produce or express novel metal binding proteins, they are also particularly useful for isolation and identification of additional metal binding protein genes encoding the novel metal binding proteins of the present invention.
  • DNA sequences encoding any of the metal binding protein isomers can be obtained. Therefore, the present invention includes nucleic acids encoding any and all of the isomeric or alternative forms of the metal binding proteins of the present invention.
  • isolated nucleic acids need not comprise entire coding sequences of an MT isomer, but include nucleic acid sequences encoding domains or portions of a coding sequence encoding an MT isomer, such as the functional or metal binding regions of the metal binding protein isomers of the present invention.
  • Another aspect of the invention is a vector comprising a nucleic acid sequence according to the present invention operatively linked to at least one control sequence that controls the expression or regulation of the nucleic acid sequence.
  • control sequences are well known in the art and include operators, promoters, enhancers, promoter-proximal elements and replication origins.
  • the techniques of vector construction including cloning, ligation, gap-filling, the use of the polymerase chain reaction (PCR) 1 solid-state oligonucleotide synthesis, and other techniques, are all well known in the art and need not be described further here.
  • the vectors of the present invention are particularly useful in producing the novel metal binding proteins either by modified organisms, host cells or other types of expression systems.
  • the metal binding proteins of the present invention can be produced in bacterial cells, insect cells, plant cells or mammalian cells. Appropriate vectors and cells for production of metal binding proteins in each of these species are well known to persons skilled in the art.
  • the metal binding proteins of the present invention include pollution control applications such as metal remediation, pollution control, metal recycling or metal mining.
  • the metal binding proteins can be used to reduce the concentration of heavy metals in an environmental substance.
  • the substance can be a fluid, such as ground water, sludge, waste-water and the like.
  • the metal binding proteins can be incorporated into one or more compositions or devices used for pollution control.
  • the metal binding proteins can be applied on site in the form of a flocculent or powder, or can be used in treatment plants as part of a membrane filtration or other type of solid support device used for removal of heavy metal from a contaminated substrate.
  • the metal binding proteins used in these metal binding processes can be provided as a product purified from its natural source or can be produced by bioengineering techniques.
  • the metal binding proteins can be produced by transgenic or modified organisms.
  • Modified organisms include transgenic animals, bacteria or plants.
  • a modified plant can be a transgenic tobacco plant whose genome has been genetically altered to express one or more metal binding protein of the present invention.
  • a modified organism can also include a plant or biomass that is capable of growing at or within contaminated sites where metal remediation is desired. Extraction of metal contaminants by the modified organisms also concentrates the toxic metals from the contaminated site. This provides the additional advantage of converting the heavy metals to a smaller quantity as well as providing final product that is more easily and safely handled for disposal or further processing.
  • Methods for reducing the concentration of heavy metals in a substrate include contacting a metal binding protein of the present invention with a substrate having heavy metals.
  • a metal binding protein having an amino acid sequence analogous to at least one metal binding protein sequence from brine shrimp (Artemia) can be contacted with a substance having a concentration of at least one heavy metal to bind the heavy metal to the metal binding protein. Subsequently, the bound heavy metal can be separated from the substrate, reducing the concentration of heavy metals in the original substrate.
  • an additional advantageous feature of the metal binding proteins of the present invention include their ability to release bound heavy metals using acid extraction, inorganic chelators, and/or exchange reaction technologies. This allows the user, if desired, to elute bound heavy metals off the metal binding proteins. Once the heavy metals are eluted off the metal binding proteins of the present invention, the metal binding proteins can be regenerated (or recycled) for additional uses in metal extraction. Therefore, the invention also provides methods for reducing the concentration of heavy metals in a substrate using reusable compositions, devices and apparatuses comprising the metal binding proteins.
  • Metal binding proteins of the present invention when used in methods for reducing the concentration of a metal in a substrate can be provided in such a way as is appropriate for the particular use, situation, mode of administration or environment in which the metal binding proteins are to be used.
  • the metal binding proteins when used in metal remediation, or in pollution control, can be coupled to a support, such as a powder and used, for example, as a flocculent to provide a convenient and efficient means of dispersing the metal binding proteins.
  • the metal binding proteins can be provided coupled to a membrane, a semi-permeable membrane, a filter, or any other means appropriate for allowing sufficient exposure of the metal binding proteins to the heavy metal containing substrate so as to bind or sequester the heavy metals from the substrate.
  • a membrane or filter comprising the metal binding proteins provides a particularly efficient means of treating ground water or waste water, as contaminated water can be purified by passage through the membrane or filter without further clean up as is required in chemical extraction processes. Coupling the metal binding proteins to a support or supporting matrix also affords easier handling of the metal binding proteins especially when used in large scale or industrial applications.
  • metal binding proteins of the present invention are not limited only to those methods where removal of heavy metals is desired, but can also include methods where recovery or concentration of heavy metals in a substance is to be achieved.
  • the metal binding proteins can be used for metal mining, such as in the recovery of precious metals including gold, platinum and silver, or can be used to concentrate metals in hazardous conditions, such as hazardous waste containing radioactive metals. Such hazardous metal waste can result either from numerous research, commercial or industrial uses.
  • Use of the metal binding proteins in concentrating radioactive metals from waste also reduces the amount or quantity of hazardous waste to be disposed of. Reducing the quantity of hazardous metal waste also reduces the level of radioactivity to which certain individuals are exposed.
  • Methods for reducing the concentration of heavy metals in a substance include producing the metal binding proteins in a modified organism.
  • Modified organisms include, for example, transgenic organisms or transgenic hosts.
  • hosts or organisms such as shrimp, plants, bacteria, yeast or algae can be modified using molecular and genetic engineering techniques well known in the art. Using these techniques, which are described for example, in Sambrook et al., Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Press, 2001 ); Ausubel et al. Current Protocols in Molecular Biology (Wiley lnterscience Publishers, 1995); US Dept Commerce/NOAA/NMFS/NWFSC Molecular Biology Protocols (URL:http://research.
  • Metal binding proteins of the present invention include metal binding proteins having an amino acid sequence analogous to at least one metal binding protein sequence from a brine shrimp (Artemia). Modified organisms can be made and used to produce these metal binding proteins, and the metal binding proteins useful in the methods provided herein.
  • a modified organism producing a metal binding protein of the present invention includes a modified organism producing at least one metal binding protein having an amino acid sequence substantially similar to a metal binding protein from a brine shrimp (Artemia).
  • a modified organism also includes an organism producing a metal binding protein having an amino acid sequence substantially similar to SEQ ID NO. 2 or conservative amino acid substitutions thereof.
  • production or expression of the metal binding proteins of the present invention from modified organisms is not limited to genomic expression of the metal binding proteins, but also includes epigenetic expression of the metal binding proteins from the modified organisms.
  • Methods and techniques for obtaining epigenetic expression from a modified organism include, for example, adenoviral, adeno-associated viral, plasmid and transient expression techniques which are known in the art.
  • the present invention includes methods for producing the metal binding proteins of the present invention.
  • a method for producing a metal binding protein having an amino acid sequence analogous to at least one metal binding protein from a brine shrimp (Artemia) includes providing an expression system, producing a metal binding protein using the expression system and purifying or isolating the metal binding proteins to obtain a metal binding protein of the present invention.
  • Expression systems can be systems such as traditional manufacturing plants.
  • organisms such as brine shrimp can be grown and the metal binding proteins of the present invention purified or extracted from the tissues of the brine shrimp.
  • biomanufacturing systems using genetically engineered organisms (produced as described herein) capable of producing the metal binding proteins can be used to produce the metal binding proteins.
  • bacteria containing a metal binding protein expression vector can be cultured on large or small scale (depending on the particular need). The metal binding proteins can then be purified from the bacterial broth and used in metal binding processes.
  • a metal binding protein of the present invention can be produced by expression of a nucleic acid sequence encoding a metal binding protein in a modified organism or host cell.
  • a nucleic acid sequence includes, for example, a MT gene such as SEQ ID NO. 1 or a sequence encoding a fragment or functional metal binding domain of a MT gene.
  • the expressed metal binding proteins are purified using standard techniques. Techniques for purification of cloned proteins are well known in the art and need not be detailed further here. One particularly suitable method of purification is affinity chromatography employing an immobilized antibody to a metal binding protein. Other protein purification methods include chromatography on ion-exchange resins, gel electrophoresis, isoelectric focusing, and gel filtration, among others. Alternatively, the metal binding proteins of the present invention can be purified following their expression from modified organisms by methods such as precipitation with reagents (e.g. ammonium sulfate, acetone or protamine sulfate as well as other methods known in the art).
  • reagents e.g. ammonium sulfate, acetone or protamine sulfate as well as other methods known in the art.
  • Artemia brine shrimp were grown in artificial seawater (AS) (422.7 mM NaCI, 7.24 mM KCL, 22.58 mM MgCI 2 « 6H 2 O, 25.52 mM MgSO 4 « 7H 2 O, 1.33 mM CaCI 2 '2H 2 O and 0.476 mM NaHCO 3 ).
  • AS artificial seawater
  • Artemia cysts 2.5 g were incubated for 48 hours in 250 mL of AS supplemented with antibiotics at 30 0 C and rotation at 125 rpm. After 24 hrs, phototropic Artemia were collected, cultured for an additional 24 hrs and then collected by cloth filtration. The shrimp were weighed and if not used immediately, stored at -80 0 C.
  • HB homogenization buffer
  • the Artemia were then homogenized in homogenization buffer (HB) (10 mM Tris-HCI (pH 8.0), 0.1 mM DTT, 0.5 mM PMSF and 10 ⁇ g/ml Soybean Trypsin Inhibitor) and resuspended in HB at 4 mL/gm wet weight of shrimp.
  • the homogenate was passed through a Yamato LH-21 homogenizer three times at a setting of 800 rpm, filtered through Miracloth (Calbiochem) and the filtrate centrifuged in a Sorvall SA-600 rotor at 14,300 rpm, 4°C for 30 min.
  • the lipid layer on top of the supernatant was removed by vacuum aspiration and the lower supernatant layer collected and centrifuged in a Beckman 50.2Tl rotor at 4OK rpm, 4 0 C for 90 min. Again, the upper lipid layer was removed and the lower supernatant recentrifuged at 150K (150K sup). The 150K sup was then used immediately or stored at -80°C. If used immediately, this product was then subjected to gel filtration as follows. The gel filtration studies verified the metal binding proteins' ability to bind to heavy metals.
  • the 150K sup was centrifuged in a Sorvall SA-600 rotor at 8,500 rpm and 4°C for 30 min. The resulting supernatant was then filtered through a HPLC certified 0.45 micron LC13 acrodisc filter (Gelman Sciences). A 20 mL aliquot of filtered 150K supernatant was incubated at 4°C for 20 min with 2 ⁇ L of 109 Cd (0.066 ⁇ Ci) to radiolabel the metal binding proteins. The sample was then applied to a Sephadex G-50 molecular weight exclusion column (2.6 cm x 94 cm) previously equilibrated with 50 mM Tris-HCI (pH 8.0) saturated with N 2 .
  • One molar DTT (2 ⁇ L) was added to fractions 60-100 prior to sample loading in order to maintain reducing conditions in the fractions containing the low molecular weight metal binding proteins.
  • the column was eluted with 50 mM Tris (pH 8.0) at a flow rate of 20 mL/hr while monitoring the eluate at 280 nm. During the elution period, the buffer reservoir was continually purged with N 2 . Samples used for amino acid analysis were not radiolabeled.
  • the 109 Cd content (CPM) of the column fractions was determined with an Auto- Logic gamma counter (ABBOTT Laboratories). Zinc content was measured by Flame or Furnace Atomic Absorption Spectroscopy and expressed as PPB zinc/fraction. Prior studies indicated that two classes of metal binding proteins were present, one class being a high molecular weight fraction. However, the majority of 109 Cd eluted with a low molecular weight class of zinc-containing metal binding protein. As shown in FIG. 1 , radioactive metal binding protein had a elution peak corresponding to that for Zinc (roughly, fraction #50). The protein concentration of the Sephadex G-50 fractions was determined with a BCA Total protein assay kit (Pierce) according to manufacturers protocol. The distinct structural features of the metal binding proteins of the present invention were then identified in the following studies.
  • Artemia metal binding proteins Under SDS-PAGE conditions, Artemia metal binding proteins have molecular weight of about 5.8 kDa as compared to 6-7 kDa for metal binding proteins from other mammalian species. Protein analysis of Artemia metal binding proteins indicate a sequence length of 48 amino acids. The Artemia MT amino acid sequence was unexpectedly and significantly shorter in length than other known metal binding proteins, which range in length from 60 to 68 amino acid residues.
  • the initial PCR Primer Sequences used were as follows: the 5' primer (N- terminal side) was designated “MT-Not I” (SEQ ID NO. 5) and the 3 1 primer (C-terminal side) was designated “dT-Spe I” (SEQ ID NO. 6, SEQ ID NO. 7, SEQ ID NO. 8, or SEQ ID NO. 9)
  • the PCR product was verified for successful amplification on a 1.2% agarose gel.
  • the PCR product was then purified for subsequent cloning using Qiagen QIAquick Gel Extraction (Qiagen, CA).
  • Qiagen QIAquick Gel Extraction
  • the following primers which contain modifying restriction sites incorporated into their sequence were used to amplify and subclone the purified PCR product containing brine shrimp Artemia metal binding protein gene sequences.
  • the Artemia MT nucleotide sequence was amplified and then subsequently subcloned into the pGEM3 vector's Eco Rl site. Once subcloned, the cloned metal binding protein gene can then be easily modified or further processed for use in expression, production or other methods requiring use of an isolated nucleic acid encoding a metal binding protein.
  • the metal binding proteins of the present invention are capable of binding heavy metals such as zinc, cadmium and copper.
  • the ability of an isolated protein to bind heavy metals was described and detailed in the disclosed transformation of E. coli with an exemplary MT of the present invention and shown, as indicated in FIG. 1.
  • modified organisms useful for producing the novel metal binding proteins of the present invention can be made following the teachings provided herein.
  • An exemplary modified organism includes a transgenic tobacco plant which is particularly useful in the methods described herein.
  • the cDNA for MT cloned into TOPO. CR2 vector is referred to as pART mt .
  • the coding sequence for the MT was cloned into a pUC18 based plasmid containing the omega 5' untranslated region of the TMV coat protein in frame with the multiple cloning site. (See FIG. 2). This was accomplished by amplification of the MT coding sequence from pART mt1 using PCR primers containing an Nco I restriction site on the 5' primer and a Sal I site on the 3' primer. The PCR product and vector were each restricted with Nco I and Sal I and purified. The PCR product was then ligated into the vector using T4 DNA ligase. The ligation mixture was used to transform DH5 ⁇ cells by electroporation. LB media was inoculated with individual colonies and grown overnight. Plasmid was isolated and sequenced to verify the presence and integrity of the MT coding sequence.
  • the Eco Rl/Xba I cassette was removed and cloned into the corresponding sites on the plant expression vector pSS.
  • the pSS vector contains the constitutive CMV promotor and transcription terminator sequence in frame with the multiple cloning site.
  • the resultant pSS mt construct was propagated in DH5 ⁇ cells, isolated and sequenced to verify the presence and integrity of the MT gene as described above.
  • A. tumefaciens were transformed with the cytosolic pSS mt construct by electroporation and grown overnight at 27°C in YEB medium, pH 7.4, containing antibiotics.
  • the cells were collected and resuspended in induction medium (YEB, pH 5.8, antibiotics and 20 ⁇ M Acetosyringone) and grown overnight at 27°C.
  • the next morning the cells were collected by centrifugation and resuspended in infiltration medium (MMA buffer containing antibiotics and 200 ⁇ M Acetosyringone) to an A 60 O of 1.5 and incubated at room temperature for 2 hrs.
  • Tobacco Naturala tabacum leaves were submerged in the bacterial suspension and placed in a vacuum dessicator.
  • the leaves were infiltrated under a vacuum of 30-40 mbar.
  • the leaves were placed at room temperature for 72 hours then ground to a fine powder in liquid nitrogen and extracted with 10 mM Tris pH 8.0, 0.05 mM DTT, 1 mM PMSF.
  • the solution was clarified by centrifugation at 30,000 x g and the supernatant assayed for MT using a 109 Cd metal binding assay. Metal binding activity is evident in the leaves containing the gene for Artemia MT (Table 1 ).
  • a suspension of A. tumefaciens transformed with pSS mt were grown as described above. Tobacco leaves were cut into small pieces (without the central vein) and transferred into sterile week glasses containing 50-100 mL of bacterial suspension (A 6O o about.1.0) and incubated at room temperature for 30 minutes. The leaf pieces were then transferred onto sterile Whatman 3MM filterpaper pre-wetted with sterile water in plastic petri dishes. The dishes were sealed with saran wrap and incubated at 26-28°C in the dark for two days. The leaf pieces were then washed with sterile water containing antibiotics and transferred onto MS Il agar plates.
  • the pieces were incubated at 25°C for 3-4 weeks with a 16 hr photoperiod.
  • the shoots were removed and transferred onto MS III agar plates and incubated at 25°C with a 16 hr photoperiod until roots began to form.
  • the small plants were transferred into week glasses containing MS III medium and incubated at 25°C with a 16 hr photoperiod for about two weeks.
  • the young plants were then planted into soil. Young leaves from the plants were collected and assayed for MT activity as described above to determine the transgenic plants.
  • Metallothionein was extracted from Artemia embryos as described above.
  • the protein extract (80 mL) was placed in a boiling water bath for 15 minutes.
  • the solution was centrifuged at 30,000 x g (16,000 rpm in a SA600 rotor) for 30 minutes at 4°C.
  • the supernatant containing the metallothionein was transferred to a clean tube containing 60 ⁇ L of 109 Cd (Amersham Biosciences).
  • the solution was mixed well and allowed to stand at room temperature for five minutes. This allows for exchange of the radioactive cadmium onto the metallothionein and provides us with a method for detecting the protein during its purification.
  • the solution was then applied to a 100 x 4.8 cm G-50 molecular exclusion column and eluted with nitrogen saturated 50 mM Tris, pH 8.0. Fifteen milliliter fractions were collected into tubes containing 25 ⁇ l_ of 1M DTT. The peak metal binding activity were pooled and stored at 4°C. The solution is referred to as MT. (See FIG. 3 through FIG 7)
  • the membrane was then washed twice, each with 10 mL of PBS. Five milliliters of the pooled eluate was analyzed of radioactivity. The membrane was removed from the filtering unit, place in a 12 x 75 mm centrifuge tube and analyzed for radioactivity in an LKB gamma counter. As a control, the procedure was repeated with a second membrane that had not been treated with MT. This membrane is referred to as the "blank.” The results are shown below in Table 2.
  • Membrane #1 (blank) was washed with 5 ml. of PBS containing radioactive cadmium. The membrane was then washed twice with 10 ml_ of non-radioactive, metal-free PBS.
  • Membrane #2 was washed first with 10 mL of MT solution and then 5 mL of PBS containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal-free PBS.
  • Membrane #3 was washed with 10 mL of MT solution and then 5 mL of 10 mM
  • the membrane was then washed twice with 10 mL of non-radioactive, metal-free 10 mM H 2 CO3/HCO3, 150 mM NaCI, pH 10.1.
  • Membrane #4 was washed with 10 mL of MT solution and then 5 mL of 10 mM glycine, 150 mM NaCI, pH 2.0, containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal-free 10 mM glycine, 150 mM NaCI, pH 2.0.
  • Membrane #2 was washed first with 10 mL of MT solution and then 5 mL of PBS containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal-free PBS.
  • Membrane #3 was pre-washed with 10 mL of metal-free 10 mM H 2 CO 3 ZHCO 3 , 150 mM
  • Binding affinity/specificity was measured against bovine serum albumin, a protein containing several cysteine residues and known to bind heavy metals.
  • the Biodyne A membrane was used for this experiment.
  • the concentration of MT solution was found to be approximately 7 ⁇ gZmL.
  • the concentration of the flow through is equivalent to the starting material indicating that the amount bound to the membrane is in ng (nanograms), thus indicating that the metal binding capacity of the protein is significant. Therefore, 7 ⁇ gZmL and 100 ⁇ gZmL solutions of BSA were made in D-PBS using the 2 mgZmL BSA standard from Pierce Chemical, Inc.
  • the cadmium binding solution was prepared as follows: 1.5 mL of aqueous 1 ppm CdCI 2 was mixed with 3 ⁇ L of 109 Cd. The solution is stored at 4°C.
  • the assay was run as follows:
  • Membrane #1 (blank) was washed with 5 mL of PBS containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal free PBS. Membrane #2 was washed first with 5 ml_ of MT solution and then 5 ml. of PBS containing radioactive cadmium. The membrane was then washed twice with 10 ml_ of non ⁇ radioactive, metal free PBS.
  • Membrane #3 was washed with 5 mL of BSA solution (7 ⁇ g/ml_)and then 5 mL of PBS containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal-free PBS.
  • Membrane #4 was washed with 10 mL of BSA solution (100 ⁇ g/mL) and then 5 mL of PBS containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal-free PBS.
  • Membrane #1 (blank) was washed with 5 mL of PBS containing radioactive cadmium. The membrane was then washed twice with 10 mL of non-radioactive, metal-free PBS.
  • Membrane #2 was washed with 10 mL of MT solution and then 5 r ⁇ Lof PBS containing radioactive cadmium pre-warmed to 6O 0 C. The membrane was then washed twice with 10 mL of non-radioactive, metal-free PBS pre-warmed to 6O 0 C.
  • Membrane #3 was washed with 10 mL of MT solution and then 5 mL of PBS containing radioactive cadmium cooled to 4°C. The membrane was then washed twice with 10 mL of non-radioactive, metal free PBS cooled to 4°C.
  • Metal remediation with the metal binding proteins of the present invention can be accomplished using metallothionein proteins from a variety of sources.
  • Rabbit liver MT was obtained as a lyophilized protein (Sigma) and solubilized in 400 ⁇ l_ of 50 mM Tris, pH 8.0, 0.001 M DTT to a final concentration of 2.5 mg/mL (rabbit MT stock solution).
  • Artemia MT was purified as described supra in Example 4.
  • Membranes were prepared having bound Artemia MT or rabbit liver MT by passing an MT-containing solution through the membrane, as described supra in Example 4. Three membranes, a blank, a membrane bound with Artemia MT and a membrane bound with rabbit liver MT, were then placed in a 13 mm scintered glass filtering unit and 10 mL of a metal binding solution (a stock solution of 9000 cpm of 109 Cd/25 ⁇ l_ of solution diluted to 75 ⁇ l_/10ml_ PBS to form the metal binding solution) was passed through the membrane under vacuum. The membrane was then washed three times in PBS, and the membrane-bound radioactivity was measured in a Packard gamma counter. In a second experiment, a larger quantity of Artemia MT was bound to the membrane. The results of these two experiments are found in Tables 7 and 8.
  • Membrane 1 Blank 231 Membrane 2 Artemia (25mL bound to the 980 membrane [0125] Membrane-bound metallothionein, regardless of source, provides removal of metals from aqueous solutions.
  • the metal binding activity is a function of the amount of protein applied to the membrane and increasing the amount of MT protein on the membrane results in increased metal binding activity by the membrane.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Processing Of Solid Wastes (AREA)
  • Water Treatment By Sorption (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

La présente invention se rapporte à des dispositifs, tels que des supports solides comportant des protéines de liaison métalliques, du type protéines métallothionéines, liées à ces supports de manière à permettre le retrait de métaux de substrats dont il est nécessaire de retirer des métaux. L'invention se rapporte à des membranes spécifiques comportant des protéines métallothionéines provenant de la crevette des salines Artemia et permettant de retirer des métaux de substrats liquides. L'invention se rapporte également à des procédés associés pour retirer des métaux de substrats au moyen de protéines métallothionéines.
EP05812434A 2004-10-19 2005-10-19 Compositions et procedes permettant de retirer des metaux lourds d'echantillons contamines au moyen de membranes comportant des proteines metallothioneines purifiees (mt) Withdrawn EP1799335A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62052804P 2004-10-19 2004-10-19
PCT/US2005/038136 WO2006045103A2 (fr) 2004-10-19 2005-10-19 Compositions et procedes permettant de retirer des metaux lourds d'echantillons contamines au moyen de membranes comportant des proteines metallothioneines purifiees (mt)

Publications (1)

Publication Number Publication Date
EP1799335A2 true EP1799335A2 (fr) 2007-06-27

Family

ID=36203739

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05812434A Withdrawn EP1799335A2 (fr) 2004-10-19 2005-10-19 Compositions et procedes permettant de retirer des metaux lourds d'echantillons contamines au moyen de membranes comportant des proteines metallothioneines purifiees (mt)

Country Status (6)

Country Link
EP (1) EP1799335A2 (fr)
JP (1) JP2008516770A (fr)
CN (1) CN101048221A (fr)
AU (1) AU2005295151A1 (fr)
CA (1) CA2584518A1 (fr)
WO (1) WO2006045103A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011119357A1 (de) 2011-11-25 2013-05-29 Heraeus Medical Gmbh Mehrkomponenten-Kartuschensystem mit verschiebbaren Verschlüssen in den Kartuschen
DE102012008815A1 (de) 2012-05-07 2013-11-07 Heraeus Medical Gmbh Mischvorrichtung für Mehrkomponentensysteme

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767872B2 (en) 2001-09-06 2010-08-03 Mpg Biotechnologies, Llc Thimerosal removal device
US8440791B2 (en) 2001-09-06 2013-05-14 Mgp Biotechnologies, Llc Thimerosal removal device
WO2007084916A2 (fr) * 2006-01-17 2007-07-26 Mgp Biotechnologies, Llc Dispositif permettant d'éliminer le thimérosal
ES2303495B1 (es) * 2008-02-04 2009-10-29 Universitat Autonoma De Barcelona Biosensor selectivo a metalotioneinas.
CN103769413A (zh) * 2012-10-23 2014-05-07 山西潞安环保能源开发股份有限公司 一种改良矿井水污染土壤及其农作物生长特性的方法
EP2921216A1 (fr) 2014-03-17 2015-09-23 ETH Zurich Procédé de recyclage de métaux lourds et matériau utilisable pour ce procédé
CA3029728A1 (fr) * 2015-07-02 2017-01-05 Mgp Biotechnologies, Inc. Compositions et procedes permettant d'extraire des metaux lourds de materiaux contamines
CN105505950B (zh) * 2016-01-29 2019-03-29 中国科学院华南植物园 五个烟草金属硫蛋白基因的新应用
CN106623379B (zh) * 2016-11-04 2020-04-07 甘肃天农一禾农业有限公司 建筑垃圾的资源回收利用方法和重金属污染土壤修复剂
CN109943571B (zh) * 2019-04-11 2022-09-02 中国科学院遗传与发育生物学研究所农业资源研究中心 一种金属硫蛋白基因mt20、其编码得到的金属硫蛋白及其表达和应用
CN111250064A (zh) * 2019-10-10 2020-06-09 浙江海洋大学 一种支化聚乙烯亚胺修饰贻贝壳粉的制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203299D0 (en) * 1992-02-17 1992-04-01 Indena Spa Cosmetic and/or pharmaceutical compositions and methods for their use
US6451260B1 (en) * 1997-08-26 2002-09-17 Dyax Corp. Method for producing microporous elements, the microporous elements thus produced and uses thereof
US6750056B2 (en) * 2001-09-06 2004-06-15 Roger A. Acey Metal binding proteins and associated methods
JP2003082422A (ja) * 2001-09-12 2003-03-19 Mitsubishi Chemicals Corp ガリウムの回収方法
JP2004000092A (ja) * 2002-05-31 2004-01-08 Foundation For Nara Institute Of Science & Technology 重金属を特異的に結合するポリペプタイドおよび当該ポリペプタイドをコードする遺伝子

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006045103A3 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011119357A1 (de) 2011-11-25 2013-05-29 Heraeus Medical Gmbh Mehrkomponenten-Kartuschensystem mit verschiebbaren Verschlüssen in den Kartuschen
EP2596873A2 (fr) 2011-11-25 2013-05-29 Heraeus Medical GmbH Système de cartouche à plusieurs composants avec fermetures mobiles dans les cartouches
US8986313B2 (en) 2011-11-25 2015-03-24 Heraeus Medical Gmbh Multi-component cartridge system with shiftable closures in the cartridges
DE102012008815A1 (de) 2012-05-07 2013-11-07 Heraeus Medical Gmbh Mischvorrichtung für Mehrkomponentensysteme
EP2662150A2 (fr) 2012-05-07 2013-11-13 Heraeus Medical GmbH Dispositif de mélange pour systèmes multicomposants

Also Published As

Publication number Publication date
CN101048221A (zh) 2007-10-03
WO2006045103A2 (fr) 2006-04-27
WO2006045103A3 (fr) 2006-08-24
JP2008516770A (ja) 2008-05-22
AU2005295151A1 (en) 2006-04-27
CA2584518A1 (fr) 2006-04-27

Similar Documents

Publication Publication Date Title
EP1799335A2 (fr) Compositions et procedes permettant de retirer des metaux lourds d'echantillons contamines au moyen de membranes comportant des proteines metallothioneines purifiees (mt)
US20070117968A1 (en) Metal binding proteins and associated methods
US7273962B2 (en) Compositions and methods for removing heavy metals from contaminated samples using membranes provided with purified metallothionein (MT) proteins
Wang et al. A novel strategy for the microbial removal of heavy metals: cell-surface display of peptides
US20200254422A1 (en) Compositions and Methods for Removing Heavy Metals from Contaminated Materials
JP2013502223A (ja) 重金属浄化システム
AU2002316183A1 (en) Metal binding proteins and associated methods
US6162900A (en) Metal-regulated transporters and uses therefor
Sun et al. Heavy metal removal through biosorptive pathways
US8440791B2 (en) Thimerosal removal device
Macek et al. Accumulation of cadmium ions by hairy root cultures
US7767872B2 (en) Thimerosal removal device
Karim et al. Phthalate esters in the environment: an overview on the occurrence, toxicity, detection, and treatment options
Fang et al. A promotion strategy of enhancing the mercury removal in Shewanella oneidensis MR-1 based on the mercury absorption and electronic consumption via mer operon
EP1976610B1 (fr) Dispositif permettant d'éliminer le thimérosal
Kumar et al. Understanding the bioaccumulation and biosorption of arsenic [As (III)] in plants and biotechnological approaches for its bioremediation
JP2001275683A (ja) 重金属吸収能を有する形質転換生物体及びそれを用いた重金属類浄化方法
Robinson Microbial Bioavailability of Residual Organic Contaminants in Soils
Macek¹ et al. Accumulation of Cadmium
Akkurt et al. Equilibrium, kinetic, and thermodynamic studies on the biosorption of lead by human metallothionein gene‐cloned bacteria as a novel biosorbent
Fitch et al. Biological fixed film systems
Bahrami et al. Investigation of sol-gel matrices containing crude metallothionein from Scchizosaccharomyces pombe for water treatment applications

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070420

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20070801

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20100506